Clinical Significance of Low Lactate Dehydrogenase (LDH) Levels
Interpretation and Management
- The American Thoracic Society and other guideline societies do not mention low LDH levels as a finding that requires evaluation or intervention, as they are not associated with specific pathologies or established diagnostic or prognostic value 1, 2, 3
- Low LDH levels are not used as a diagnostic or prognostic marker in any disease, whereas elevated LDH levels are used as a biomarker in various diseases, including neoplasias and pleural diseases 4, 5, 6
- In the context of neoplasias, such as lymphomas and testicular cancer, LDH is used as a diagnostic and prognostic marker, with elevated levels indicating a poorer prognosis 4, 5
- The National Comprehensive Cancer Network recommends using LDH as a diagnostic marker in multiple myeloma and as a marker of response to treatment in adult T-cell leukemia/lymphoma 4, 7
Diagnostic and Prognostic Contexts
- LDH is used to distinguish between exudates and transudates in pleural diseases, using the Light criteria 1, 6
- Elevated LDH levels are associated with a poorer prognosis in small cell lung cancer, whereas low LDH levels do not have established prognostic value 8
Clinical Significance of Lactate Dehydrogenase (LDH) Levels in Cancer Prognosis
Prognostic Value of LDH in Cancer
- The American Joint Committee on Cancer and other guideline societies recommend using LDH levels as a prognostic indicator in melanoma, with LDH <1.5× upper limit of normal associated with better outcomes 9
- In osteosarcoma, normal LDH levels correlate with better disease-free survival rates, as stated by the National Comprehensive Cancer Network 10
- In follicular lymphoma, LDH is part of the prognostic scoring system (FLIPI), according to the European Society for Medical Oncology 11